Davey B. Daniel

机构：SUNY Oneonta, Tennessee Oncology · ORCID：0000-0001-9647-0119

发表论文 153 篇 · 总被引 13964 次 · h-index 28

代表论文

A rising tide lifts all boats in the personalized cancer care continuum for mNSCLC: bridging inequities in NGS fosters equity in targeted treatment (2025 · The Oncologist · 被引 3)
Longer follow-up for survival and safety from the EVOKE-01 trial of sacituzumab govitecan (SG) vs docetaxel in patients (pts) with metastatic non-small cell lung cancer (mNSCLC). (2025 · Journal of Clinical Oncology · 被引 2)
Durvalumab Consolidation in Limited-Stage SCLC: Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC Trial (2026 · Journal of Thoracic Oncology · 被引 1)
Figure 3 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study (2026)
Supplementary Figure S3 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study (2026)
Supplementary Figure S2 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study (2026)